Robbie Marcus
Stock Analyst at J.P. Morgan
(4.31)
# 1,361
Out of 4,988 analysts
535
Total ratings
51.9%
Success rate
7.3%
Average return
Main Sectors:
Stocks Rated by Robbie Marcus
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| COO The Cooper Companies | Rated: Hold | $71 → $58 | $55.29 | +4.90% | 21 | Sep 10, 2026 | |
| MDT Medtronic | Reiterated: Hold | $86 → $96 | $92.13 | +4.20% | 27 | Sep 3, 2026 | |
| ABT Abbott Laboratories | Reiterated: Buy | n/a | $102.61 | - | 19 | Sep 1, 2026 | |
| ZBH Zimmer Biomet Holdings | Reiterated: Hold | $95 → $117 | $95.36 | +22.69% | 18 | Aug 17, 2026 | |
| HTFL HeartFlow | Reiterated: Buy | $35 → $45 | $50.75 | -11.33% | 6 | Aug 14, 2026 | |
| MOBI Mobia Medical | Reiterated: Buy | $15 → $17 | $10.54 | +61.29% | 2 | Aug 12, 2026 | |
| BDX Becton, Dickinson and Company | Reiterated: Hold | $190 → $188 | $180.94 | +3.90% | 14 | Aug 10, 2026 | |
| ENOV Enovis | Reiterated: Hold | $33 → $28 | $18.04 | +55.21% | 6 | Aug 10, 2026 | |
| KMTS Kestra Medical Technologies | Initiated Coverage: Buy | $30 | $24.43 | +22.80% | 1 | Aug 10, 2026 | |
| BAX Baxter International | Reiterated: Hold | $19 → $26 | $22.80 | +14.04% | 24 | Aug 6, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Sell | $9 → $6 | $5.20 | +15.38% | 19 | Aug 6, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgraded: Hold | $275 → $152 | $140.60 | +8.11% | 26 | Aug 5, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Hold | $82 | $89.35 | -8.23% | 27 | Aug 4, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Sell | $11 → $17 | $15.22 | +11.70% | 21 | Aug 4, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Hold | $54 → $60 | $76.78 | -21.85% | 21 | Aug 4, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $95 | $85.37 | +11.28% | 6 | Aug 4, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $350 | $275.12 | +27.22% | 19 | Aug 4, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Rated: Buy | $56 | $43.34 | +29.21% | 28 | Jul 30, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Rated: Hold | $40 → $45 | $45.42 | -0.92% | 20 | Jul 30, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Rated: Hold | $65 → $70 | $64.13 | +9.15% | 5 | Jul 30, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $105 | $88.26 | +18.97% | 25 | Jul 28, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $450 | $393.33 | +14.41% | 20 | Jul 21, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Sell | $6 | $3.04 | +97.37% | 16 | May 12, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Upgraded: Buy | $275 → $370 | $317.60 | +16.50% | 25 | Dec 18, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $21 → $17 | $24.37 | -30.24% | 5 | Nov 5, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Hold | $13 → $16 | $16.85 | -5.04% | 13 | Oct 30, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Sell | $9 → $7 | $5.14 | n/a | 27 | Aug 8, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Hold | $13 → $7 | $12.91 | n/a | 8 | May 6, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $40 → $51 | $58.10 | n/a | 20 | Feb 11, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiated Coverage: Buy | $9 → $14 | $14.28 | n/a | 10 | Dec 17, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgraded: Hold | $15 → $8 | $4.49 | n/a | 7 | May 8, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Sell | $80 → $85 | $163.81 | n/a | 13 | May 6, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgraded: Hold | $95 | $109.33 | n/a | 14 | Apr 12, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiated Coverage: Buy | $34 | $86.42 | n/a | 1 | May 28, 2019 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Upgraded: Buy | $40 | $16.45 | n/a | 1 | Jun 8, 2018 |
The Cooper Companies
Sep 10, 2026
Rated: Hold
Price Target: $71 → $58
Current: $55.29
Upside: +4.90%
Medtronic
Sep 3, 2026
Reiterated: Hold
Price Target: $86 → $96
Current: $92.13
Upside: +4.20%
Abbott Laboratories
Sep 1, 2026
Reiterated: Buy
Price Target: n/a
Current: $102.61
Upside: -
Zimmer Biomet Holdings
Aug 17, 2026
Reiterated: Hold
Price Target: $95 → $117
Current: $95.36
Upside: +22.69%
HeartFlow
Aug 14, 2026
Reiterated: Buy
Price Target: $35 → $45
Current: $50.75
Upside: -11.33%
Mobia Medical
Aug 12, 2026
Reiterated: Buy
Price Target: $15 → $17
Current: $10.54
Upside: +61.29%
Becton, Dickinson and Company
Aug 10, 2026
Reiterated: Hold
Price Target: $190 → $188
Current: $180.94
Upside: +3.90%
Enovis
Aug 10, 2026
Reiterated: Hold
Price Target: $33 → $28
Current: $18.04
Upside: +55.21%
Kestra Medical Technologies
Aug 10, 2026
Initiated Coverage: Buy
Price Target: $30
Current: $24.43
Upside: +22.80%
Baxter International
Aug 6, 2026
Reiterated: Hold
Price Target: $19 → $26
Current: $22.80
Upside: +14.04%
Aug 6, 2026
Reiterated: Sell
Price Target: $9 → $6
Current: $5.20
Upside: +15.38%
Aug 5, 2026
Downgraded: Hold
Price Target: $275 → $152
Current: $140.60
Upside: +8.11%
Aug 4, 2026
Reiterated: Hold
Price Target: $82
Current: $89.35
Upside: -8.23%
Aug 4, 2026
Reiterated: Sell
Price Target: $11 → $17
Current: $15.22
Upside: +11.70%
Aug 4, 2026
Reiterated: Hold
Price Target: $54 → $60
Current: $76.78
Upside: -21.85%
Aug 4, 2026
Reiterated: Buy
Price Target: $95
Current: $85.37
Upside: +11.28%
Aug 4, 2026
Reiterated: Buy
Price Target: $350
Current: $275.12
Upside: +27.22%
Jul 30, 2026
Rated: Buy
Price Target: $56
Current: $43.34
Upside: +29.21%
Jul 30, 2026
Rated: Hold
Price Target: $40 → $45
Current: $45.42
Upside: -0.92%
Jul 30, 2026
Rated: Hold
Price Target: $65 → $70
Current: $64.13
Upside: +9.15%
Jul 28, 2026
Reiterated: Buy
Price Target: $105
Current: $88.26
Upside: +18.97%
Jul 21, 2026
Reiterated: Buy
Price Target: $450
Current: $393.33
Upside: +14.41%
May 12, 2026
Reiterated: Sell
Price Target: $6
Current: $3.04
Upside: +97.37%
Dec 18, 2025
Upgraded: Buy
Price Target: $275 → $370
Current: $317.60
Upside: +16.50%
Nov 5, 2025
Reiterated: Buy
Price Target: $21 → $17
Current: $24.37
Upside: -30.24%
Oct 30, 2025
Reiterated: Hold
Price Target: $13 → $16
Current: $16.85
Upside: -5.04%
Aug 8, 2025
Reiterated: Sell
Price Target: $9 → $7
Current: $5.14
Upside: n/a
May 6, 2025
Reiterated: Hold
Price Target: $13 → $7
Current: $12.91
Upside: n/a
Feb 11, 2025
Reiterated: Buy
Price Target: $40 → $51
Current: $58.10
Upside: n/a
Dec 17, 2024
Initiated Coverage: Buy
Price Target: $9 → $14
Current: $14.28
Upside: n/a
May 8, 2024
Downgraded: Hold
Price Target: $15 → $8
Current: $4.49
Upside: n/a
May 6, 2021
Reiterated: Sell
Price Target: $80 → $85
Current: $163.81
Upside: n/a
Apr 12, 2021
Downgraded: Hold
Price Target: $95
Current: $109.33
Upside: n/a
May 28, 2019
Initiated Coverage: Buy
Price Target: $34
Current: $86.42
Upside: n/a
Jun 8, 2018
Upgraded: Buy
Price Target: $40
Current: $16.45
Upside: n/a